Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Video summary

Horvath Clock described: DNA methylation and biological age

The description presents the Horvath Clock, published in 2013, as an epigenetic clock built from DNA methylation data across 51 tissue types and thousands of people, tracking biological age with an average error of 3.6 years. It also says partial epigenetic reprogramming aims to reset the cellular clock. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says Horvath's 2013 paper used data from 51 tissue types and thousands of individuals and tracked biological age with an average error of 3.6 years. [1]

  2. The description mentions a seven-year cross-species methylation study with 200 researchers and says long-lived species have protected methylation valleys that short-lived species lack. [1]

  3. The description says researchers are using partial epigenetic reprogramming to attempt to reset the cellular clock. [1]

The source at a glance

Study type / format
Video description of an interview about published research and proposed reprogramming work
Population / context
Human DNA data across 51 tissue types and thousands of individuals, plus cross-species methylation research, as described.
Summary based on
Creator description
Original publication
March 24, 2026

Horvath Clock built from 51 tissue types

According to the description, Dr. Steve Horvath published a paper in 2013 using data from 51 tissue types and thousands of individuals. He identified a molecular signature inside human DNA that tracks biological age with an average error of just 3.6 years. He called it the epigenetic clock, later known as the Horvath Clock. The description says the clock measures biological age and is described as more predictive than birthdate.

Supporting source [1]

Cross-species methylation and protected valleys

The description mentions a cross-species methylation study lasting seven years with 200 researchers, which it calls one definitive answer. It says the interview covers what seven years of cross-species research revealed about the relationship between methylation dynamics and maximum lifespan. It also states that long-lived species have fundamentally different epigenetic landscapes than short-lived ones, including 'protected methylation valleys' that short-lived species lack.

Supporting source [1]

Reprogramming as a proposed reversal target

The description says the discovery gave scientists a target for reversal. Researchers including David Sinclair (Harvard), Morgan Levine and the team at Life Biosciences are described as building on Horvath's foundation, using partial epigenetic reprogramming to attempt to reset the cellular clock itself. The video is said to cover how partial epigenetic reprogramming attempts to reverse aging at the cellular level. These are described aims and research directions, not demonstrated human lifespan benefits.

Supporting source [1]

How to interpret this

This is based only on the video description; the video and transcript were not reviewed. The description gives no study design details, sample sizes, follow-up or peer-review status for the cited work, and the reprogramming content is described as an attempt, not a demonstrated human outcome.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    51 tissue types and thousands of individuals
  2. Finding 2 ↑

    protected methylation valleys
  3. Finding 3 ↑

    reset the cellular clock itself

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…